 | Up a level |
Roohani, Siyer; Ehret, Felix; Beck, Marcus; Veltsista, Danai P; Nadobny, Jacek; Zschaeck, Sebastian; Abdel-Rahman, Sultan; Eckert, Franziska; Flörcken, Anne; Issels, Rolf D; Klöck, Stephan; Krempien, Robert; Lindner, Lars H; Notter, Markus; Ott, Oliver J; Pink, Daniel; Potkrajcic, Vlatko; Reichardt, Peter; Riesterer, Oliver; Spałek, Mateusz Jacek; ... (2024). Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers. International journal of hyperthermia, 41(2342348) Taylor & Francis 10.1080/02656736.2024.2342348
Strnad, Vratislav; Polgár, Csaba; Ott, Oliver J; Hildebrandt, Guido; Kauer-Dorner, Daniela; Knauerhase, Hellen; Major, Tibor; Łyczek, Jarosław; Guinot, Jose Luis; Gutierrez Miguelez, Cristina; Slampa, Pavel; Allgäuer, Michael; Lössl, Kristina; Polat, Bülent; Fietkau, Rainer; Schlamann, Annika; Resch, Alexandra; Kulik, Anna; Arribas, Leo; Niehoff, Peter; ... (2023). Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial. The lancet oncology, 24(3), pp. 262-272. Elsevier 10.1016/S1470-2045(23)00018-9
Schäfer, Rebekka; Strnad, Vratislav; Polgár, Csaba; Uter, Wolfgang; Hildebrandt, Guido; Ott, Oliver J; Kauer-Dorner, Daniela; Knauerhase, Hellen; Major, Tibor; Lyczek, Jaroslaw; Guinot, Jose Luis; Dunst, Jürgen; Miguelez, Cristina Gutierrez; Slampa, Pavel; Allgäuer, Michael; Lössl, Kristina; Kovács, György; Fischedick, Arnt-René; Fietkau, Rainer; Resch, Alexandra; ... (2018). Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. The lancet oncology, 19(6), pp. 834-844. Elsevier 10.1016/S1470-2045(18)30195-5
Polgár, Csaba; Ott, Oliver J; Hildebrandt, Guido; Kauer-Dorner, Daniela; Knauerhase, Hellen; Major, Tibor; Lyczek, Jaroslaw; Guinot, José Luis; Dunst, Jürgen; Miguelez, Cristina Gutierrez; Slampa, Pavel; Allgäuer, Michael; Lössl, Kristina; Polat, Bülent; Kovács, György; Fischedick, Arnt-René; Fietkau, Rainer; Resch, Alexandra; Kulik, Anna; Arribas, Leo; ... (2017). Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet oncology, 18(2), pp. 259-268. Elsevier 10.1016/S1470-2045(17)30011-6
Ott, Oliver J; Strnad, Vratislav; Hildebrandt, Guido; Kauer-Dorner, Daniela; Knauerhase, Hellen; Major, Tibor; Łyczek, Jaroslaw; Guinot, José Luis; Dunst, Jürgen; Miguelez, Cristina Gutierrez; Slampa, Pavel; Allgäuer, Michael; Lössl, Kristina; Polat, Bülent; Kovács, György; Fischedick, Arnt-René; Wendt, Thomas G; Fietkau, Rainer; Kortmann, Rolf-Dieter; Resch, Alexandra; ... (2016). GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance. Radiotherapy and oncology, 120(1), pp. 119-123. Elsevier 10.1016/j.radonc.2016.06.019
Strnad, Vratislav; Ott, Oliver J; Hildebrandt, Guido; Kauer-Dorner, Daniela; Knauerhase, Hellen; Major, Tibor; Lyczek, Jaroslaw; Guinot, Jose Luis; Dunst, Jürgen; Miguelez, Cristina Gutierrez; Slampa, Pavel; Allgäuer, Michael; Lössl, Kristina; Polat, Bülent; Kovács, György; Fischedick, Arnt-René; Wendt, Thomas G; Fietkau, Rainer; Hindemith, Marion; Resch, Alexandra; ... (2015). 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet, 387(10015), pp. 229-238. Elsevier 10.1016/S0140-6736(15)00471-7
